Growth Equity Opportunities Fund, LLC

Filings by Growth Equity Opportunities Fund, LLC span 2 companies, the busiest being Viracta Therapeutics, Inc. and ARYx Therapeutics, Inc. Between 30 June 2010 and 29 August 2014, the trades on record add up to 8 filings.

On the open market, the record shows 1 purchase worth €5.2M and 6 sales worth €5.4M. Taken together, the sales exceed the purchases by €134k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2014: no purchases and 5 sales on the market.

The latest filing, published on 29 August 2014, reports an open-market sale of €671k in Viracta Therapeutics, Inc. The most recent open-market purchase was published on 2 July 2010, 5,974 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.